Main content 1 Menu 2 Search 3 Footer 4
+A
A
-A
High contrast
HOME JOURNAL CRITERIA NETWORK HELP ABOUT

Current criteria:

Regional:

WPRlM journal selection criteria(2023)

Minimum standards for the suspension and removal of WPRIM approved journals

Countries journal selection criteria:

Philippines

Submit your journal information>

Contact NJSCs>

Organ Transplantation

2002 (v1, n1) to Present ISSN: 1671-8925

Articles

About

Year of publication

Save Email

Sort by

Best match
Relevance
PubYear
JournalTitle

DISPLAY OPTIONS

Format:

Per page:

Save citations to file

Selection:

Format:

Create file Cancel

Email citations

To:

Please check your email address first!

Selection:

Format:

Send email Cancel

919

results

page

of 92

1

Cite

Cite

Copy

Share

Share

Copy

The function of regulatory immunological cell in xenotransplantation immunity

Bingyi SHI ; Wen CHEN ; Zhijia LIU

Organ Transplantation.2020;11(3):321-. doi:10.3969/j.issn.1674-7445.2020.03.001

Xenotransplantation is the most promising method to resolve the organ shortage problem in the future. In recent years, the advances in gene editing and immunological technique have driven the rapid development of xenotransplantation. However, there are still many insurmountable obstacles in the clinical application of xenotransplantation, among which the rejection is the most important cause of the xenotransplantation failure. Regulatory immunological cells are a group of immunological cells with the negative regulation function in the body, which can inhibit allotransplantation rejection and prolong the survival time of the graft. This paper summarized the research progress of regulatory immunological cells in the xenotransplantation application in recent years, providing reference for the prevention and treatment of xenotransplantation rejection.

2

Cite

Cite

Copy

Share

Share

Copy

Clinical progress of diagnostic and evaluation criteria for liver transplantation in patients with severe liver disease

Yanan JIA ; Han LI ; Xianliang LI ; Qiang HE

Organ Transplantation.2020;11(3):326-. doi:10.3969/j.issn.1674-7445.2020.03.002

Liver transplantation, although recognized as the only effective radical treatment for severe liver disease, might be accompanied by high surgical risks, high perioperative mortality and high postoperative complications. Considering the shortage of donor liver and related surgical risks, it is necessary to strictly control the indication of operation and the opportunity of transplantation. Therefore, accurate diagnosis and comprehensive evaluation of the condition of patients with severe liver disease to be treated by liver transplantation is an important part in determining the treatment plan. At present, there are many evaluation criteria for severe liver disease. In addition to the classic ChildTurcotte-Pugh (CTP) score and model for end-stage liver disease (MELD) score, many other evaluation criteria have also been developed. All transplant centers have their own choices and thus there is no uniform diagnostic criterion, with disputes among various criteria, which is exactly what this paper aims to summarize.

3

Cite

Cite

Copy

Share

Share

Copy

Clinical technical specification for combined pancreas-kidney transplantation(2020 edition)

Organ Transplantation.2020;11(3):332-. doi:10.3969/j.issn.1674-7445.2020.03.003

In order to further standardize the clinical techniques for combined pancreas-kidney transplantation, organ transplant specialists under the arrangement of Branch of Organ Transplantation of Chinese Medical Association have formulated this criterion from the aspects of diabetic kidney disease typing diagnosis, indications and contraindications of combined pancreas-kidney transplantation, surgery and surgical complications, immunosuppression programs, rejection, pathology, postoperative recurrent diabetes, follow-up of recipients, etc.

4

Cite

Cite

Copy

Share

Share

Copy

Progress of immunosuppressant management, infection prevention and treatment after liver transplantation in severe liver disease

Han LI ; Yanan JIA ; Qiang HE ; Xianliang LI

Organ Transplantation.2020;11(3):344-. doi:10.3969/j.issn.1674-7445.2020.03.004

Liver transplantation is an effective treatment of severe liver disease. However, the pathophysiological changes of patients with severe liver disease are complicated, which significantly increase the difficulty of perioperative management of liver transplantation. Therefore, it is of great significance to strengthen postoperative management of the recipients with severe liver disease after liver transplantation. In this article, the pathophysiological characteristics of severe liver disease, the selection of immunosuppressant after liver transplantation, and the prevention and treatment of infection after liver transplantation in patients with severe liver disease were summarized.

5

Cite

Cite

Copy

Share

Share

Copy

Evaluation of clinical prognosis of liver transplant recipients of hepatocellular carcinoma complicated with microvascular invasion

Ziming LIANG ; Linsen YE ; Hui TANG ; Laien SONG ; Shijie GU ; Shuhong YI

Organ Transplantation.2020;11(3):350-. doi:10.3969/j.issn.1674-7445.2020.03.005

Objective To investigate the clinical prognosis of the liver transplant recipients diagnosed with hepatocellular carcinoma (HCC) complicated with microvascular invasion (MVI). Methods Clinical data of 3 447 HCC recipients undergoing liver transplantation were extracted from Surveillance, Epidemiology, and End Results (SEER) database of American National Cancer Institute. According to the incidence of MVI, all recipients were divided into MVI (n=376) and non-MVI groups (n=3 071). The clinical prognosis of liver transplant recipients was statistically compared between two groups by analyzing the 1-, 3- and 5-year overall survival (OS) and liver cancer specific survival (LCSS). Relevant clinical data including age, gender, race, pathological staging, tumor size, lymph node metastasis, distant metastasis, tumor-node-metastasis (TNM) staging and MVI were recorded in two groups. The independent risk factors of clinical prognosis of HCC recipients undergoing liver transplantation were analyzed by multivariate Cox regression model. The nomogram for predicting the clinical prognosis of the recipients was delineated. The accuracy of the prediction model was evaluated by the consistency index. Results In the non-MVI group, the 1-, 3-, 5-year OS and LCSS were 93.5%, 82.1%, 75.3% and 98.3%, 93.8%, 90.7%, significantly higher than 88.8%, 72.1%, 68.4% and 95.3%, 83.1%, 80.4% in the MVI group (all P < 0.05). Multivariate regression analysis showed that pathological staging, tumor size, lymph node metastasis, distant metastasis, TNM staging and MVI were the independent risk factors of OS and LCSS in HCC recipients undergoing liver transplantation (all P < 0.05). The nomogram consistency index was calculated as 0.624 (0.602-0.648). Conclusions MVI is an independent risk factor of the clinical prognosis of HCC recipients undergoing liver transplantation, which is significantly correlated with poor prognosis of the recipients. The nomogram based on MVI can predict the clinical prognosis of these recipients.

6

Cite

Cite

Copy

Share

Share

Copy

Comparison between different perfusion methods for donor liver acquisition in rat liver transplantation model under direct vision of single operator

Lei LI ; Shanbao LI ; Tao WANG ; Qi WO ; Wanyue CAO ; Junming XU

Organ Transplantation.2020;11(3):356-. doi:10.3969/j.issn.1674-7445.2020.03.006

Objective To establish a rat liver transplantation model under direct vision of single operator and to explore the effect of different perfusion methods on the quality of the donor liver. Methods On the basis of the "two-cuff method" established by Kamada, the operation details were improved to established the rat liver transplantation model. The recipient rats were divided into two groups according to different perfusion methods, group A (perfusion via abdominal aorta) and group B (perfusion via portal vein). The perfusion effect, operation time, operation success rate, postoperative liver function, liver graft pathological manifestations and survival were compared between the two groups. Results There were more residual red blood cells in sinus hepaticus in group B than in group A after perfusion. Both the donor liver perfusion time and donor operation time were longer in group A than those in group B, and the differences were statistically significant (both P < 0.01). The success rate of operation in group A and group B was 77% and 71%, respectively. At 3 d after liver transplantation in rats, the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and total bilirubin (TB) of the rats in the two groups were significantly higher than normal. At 7, 30 d after operation, compared with group A, the levels of ALT, AST and TB in group B were significantly increased, and the differences were statistically significant (all P < 0.01-0.05). The liver pathological examination showed that the degree of inflammatory reaction in the liver and degree of destruction of liver tissue in group B were more severe than those in group A, but there was no significant difference in long-term survival rate between the two groups. Conclusions Although the perfusion time and donor operation time of rat liver transplantation model were slightly prolonged by means of abdominal aorta perfusion, the perfusion effect was better, which can reduce liver tissue damage after operation and restore liver function to normal levels more quickly.

7

Cite

Cite

Copy

Share

Share

Copy

Establishment and analysis of mouse model of acute antibody-mediated rejection in heart transplantation

Tao LIAO ; Zhe YANG ; Yannan ZHANG ; Fei HAN ; Qiquan SUN

Organ Transplantation.2020;11(3):362-. doi:10.3969/j.issn.1674-7445.2020.03.007

Objective To establish a mouse model of acute antibody-mediated rejection (AMR) in heart transplantation and to analyze its characteristics. Methods Mouse models of heart transplantation and skin transplantation were established. According to different treatment methods, all animals were divided into the homologous control group, non-sensitized group, pre-sensitized group and pre-sensitized+ ciclosporin group (9 donors and 9 recipients in each group). The graft survival time, donor-specific antibody (DSA) level and pathological manifestations of each group were observed, and the characteristics of rejection were analyzed. Results In the homologous control group, the cardiac grafts of the mice survived for a long period of time during the 3-month observation period. The survival time of the cardiac grafts in the non-sensitized group, pre-sensitized group and pre-sensitized+ciclosporin group was (7.0±0.7) d, (2.6±0.5) d and (5.0±0.7) d, respectively. The differences among the groups were statistically significant (all P < 0.01). The DSA level in the pre-sensitized group was significantly elevated than the baseline level at 3 d after heart transplantation, and that in the pre-sensitized+ciclosporin group was remarkably up-regulated at 5 d after heart transplantation, the differences were statistically significant (P < 0.05, P < 0.01). The pathological manifestation of the non-sensitized group was the myocardial cell destruction, the formation of interstitial inflammation, mild C4d deposition and a large amount of CD3 cell infiltration. The pathological manifestations of the pre-sensitized group and the pre-sensitized+ciclosporin group showed myocardial cell destruction, capillary inflammation and a large amount of C4d deposition, whereas the amount of CD3 cell infiltration in the pre-sensitized group was more than that in the pre-sensitized+ciclosporin group. Conclusions The use of ciclosporin on the basis of heart transplantation and skin transplantation between different strains of mice can successfully establish a practical acute AMR model in mouse heart transplantation, which provides the basis for subsequent AMR pathogenesis and intervention research.

8

Cite

Cite

Copy

Share

Share

Copy

Comparison of the accuracy of RIFLE, AKIN and KDIGO criteria in predicting early death after liver transplantation

Xun LIU ; Mei XUE ; Anshi WU

Organ Transplantation.2020;11(3):369-. doi:10.3969/j.issn.1674-7445.2020.03.008

Objective To compare the accuracy of three acute kidney injury (AKI) criteria of RIFLE, Acute Kidney Injury Network (AKIN) and Kidney Disease: Improving Global Outcomes (KDIGO) in predicting the early (30 d) postoperative death of liver transplant recipients. Methods Clinical data of 173 liver transplant recipients were retrospectively analyzed. The incidence of postoperative AKI was calculated according to the three criteria of RIFLE, AKIN and KDIGO. The all-cause fatality rate and cause of death at postoperative 30 d were analyzed. The risk factors of death within 30 d after operation were analyzed by binary Logistic regression. The prediction accuracy of three criteria for death within 30 d after operation was compared by the receiver operating characteristic (ROC) curve. Results According to the RIFLE, AKIN and KDIGO criteria, the incidences of postoperative AKI were 48.0%, 51.4% and 53.8%, respectively. Thirteen patients died within 30 d after operation and the fatality rate was 7.5%. RIFLE, AKIN and KDIGO stages were the independent risk factors for death within 30 d after operation (all P < 0.05). The area under the curve (AUC) of RIFLE, AKIN and KDIGO stages to predict death within 30 d after liver transplantation were 0.828, 0.766 and 0.844, respectively. There was a statistically significant difference between AKIN and KDIGO (P < 0.05). Conclusions KDIGO criterion is better for predicting early death after liver transplantation. However, as a tool, the comparative selection among these three criteria still needs the evidence support from a large multicenter sample.

9

Cite

Cite

Copy

Share

Share

Copy

Effect of low postoperative platelet count on early fatality rate of adult liver transplantation without platelet transfusion during operation

Sainan WANG ; Zhitao WU ; Yan WU ; Anshi WU

Organ Transplantation.2020;11(3):374-. doi:10.3969/j.issn.1674-7445.2020.03.009

Objective To investigate the effect of low platelet (PLT) count on the early fatality rate of liver transplant recipients without intraoperative PLT transfusion. Methods Clinical data of 180 recipients undergoing orthotopic liver transplantation were retrospectively analyzed. The critical value of PLT count on postoperative 7 d to predict the early postoperative fatality rate was evaluated by the receiver operating characteristic(ROC) curve. All recipients were divided into the low PLT count group and control group according to the critical value. Relevant clinical data including perioperative PLT count, preoperative general conditions and intraoperative conditions of the recipients were included. The independent risk factors of the early fatality rate of liver transplant recipients were analyzed by Logistic regression analysis. The early prognosis of the recipients between two groups was observed and compared by the postoperative length of intensive care unit (ICU) stay, postoperative length of hospital stay, early allograft dysfunction and fatality rate on postoperative 30 d. Results The PLT count < 32×109/L on 7 d after liver transplantation was an independent risk factor of the fatality rate on postoperative 30 d (P < 0.05). The postoperative length of ICU stay of the recipients in the low PLT count group was 9 (5, 14) d, significantly longer than 5 (3, 6) d in the control group (P < 0.05). In the low PLT count group, the early allograft dysfunction rate was 55.0%, significantly higher than 20.6% in the control group (P < 0.05). In the low PLT count group, the fatality rate on postoperative 30 d was 40.0%, significantly higher than 2.5% in the control group (P < 0.05). The length of hospital stay did not significantly differ between two groups (P > 0.05). Conclusions The PLT count < 32×109/L on postoperative 7 d is an independent risk factor for the fatality rate on postoperative 30 d of liver transplant recipients. It can prompt the early allograft dysfunction and contribute to predict the early clinical prognosis of liver transplant recipients.

10

Cite

Cite

Copy

Share

Share

Copy

The efficiency study on different scoring models in predicting delayed graft function after renal transplantation

Yuxi QIAO ; Chenguang DING ; Puxun TIAN ; Xiaoming DING ; Xiaoming PAN ; Hang YAN ; Heli XIANG ; Xinshun FENG ; Jun HOU ; Xiaohui TIAN ; Yang LI ; Jin ZHENG ; Wujun XUE

Organ Transplantation.2020;11(3):379-. doi:10.3969/j.issn.1674-7445.2020.03.010

Objective To analyze the prediction efficiency of scoring models at home and abroad on delayed graft function (DGF) after renal transplantation in China. Methods The clinical data of 112 donors and 220 recipients undergoing renal transplantation were prospectively analyzed. The DGF predicted by KDRI model, Jeldres model, and model of our center was compared with actual DGF incidence of renal transplant recipients. The prediction efficiency of each model was analyzed. The predictive accuracy was compared by the area under curve (AUC) of receiver operating characteristic (ROC) curve. Results The DGF incidence of 220 renal transplant recipients was 14.1% (31/220). DGF prediction using KDRI model showed that 41 cases were high risk donors, the AUC was 0.57, the sensitivity was 0.37, the specificity was 0.66, and the positive predictive value was 22%. DGF prediction using Jedres model showed that 22 cases were high risk recipients, the AUC was 0.56, the sensitivity was 0.13, the specificity was 0.92 and the positive predictive value was 20%. DGF prediction using the model of our center showed that 25 cases were high risk donors, the AUC was 0.80, the sensitivity was 0.53, the specificity was 0.84, the positive predictive value was 40%. Conclusions Compared with the KDRI and Jedres models, the prediction model of our center has higher AUC and sensitivity with a better prediction efficiency on DGF. Therefore, it is a suitable evaluation system of donors from donation after citizen's death in Chinese.

Country

China

Publisher

Editorial Department of Organ Transplantation, Periodical Center of the Third Affiliated Hospital of Sun Yat-sen University

ElectronicLinks

http://www.organtranspl.com

Editor-in-chief

Chen Guihua

E-mail

organtranspl@163.com

Abbreviation

Organ Transpl

Vernacular Journal Title

器官移植

ISSN

1674-7445

EISSN

Year Approved

2017

Current Indexing Status

Currently Indexed

Start Year

2010

Description

Organ Transplantation is an international academic journal with the Ministry of Education of the People's Republic of China as the responsible institution. It is sponsored by Sun Yat-sen University, and co-hosted by the Third Affiliated Hospital of Sun Yat-sen University. Organ Transplantation serves a wide scope of readership including physicians, nurses, fundamental researchers and medical students in the field of organ transplantation and relevant disciplines, such as the Department of Transplantation Surgery, Internal Medicine, Anesthesiology and Intensive Care Unit ,etc. Organ Transplantation primarily reports novel advancement in the basic and clinical research in the field of organ transplantation at home and abroad, serving as a platform to promote academic exchanges in organ transplantation among global researchers. Up to now, four academic journals related to organ transplantation have been established in China. Compared with its counterparts, Organ Transplantation places the submission quality on the top priority. It includes Guideline & Consensus, Editorial, Clinical research, Experimental research and Review, which mainly cover liver, renal, lung and cardiac transplantation, etc. A majority of submissions originate from large transplantation centers and institutions throughout China. Special issues are designed and published annually based upon the research highlights, which gains widespread recognition from global readers. According to the latest Chinese S&T Journal Citation Reports, the impact factor of Organ Transplantation reaches 0.788, ranking 1st among all organ transplantation-related academic journals in China. In 2013, the Ministry of Health of the People's Republic of China promulgated legal regulations that all transplanted organs should be sourced from organ donation from voluntary civilian organ donors. The legitimacy of organ transplantation in China has been gradually supported by the international community. The quantity of organ transplantation surgeries performed in China is one of the largest around the globe. In recent years, both fundamental research (such as transplantation immunity and xenotransplantation) and clinical studies (like organ transplantation from living unrelated donors and donation after cardiac death) have been intensively investigated in China. Organ Transplantation strives to demonstrate these basic and clinical accomplishments of Chinese scholars to the outside world.

Related Sites

WHO WPRO GIM

Help Accessibility
DCMS Web Policy
CJSS Privacy Policy

Powered by IMICAMS( 备案号: 11010502037788, 京ICP备10218182号-8)

Successfully copied to clipboard.